Showing 1 - 10 of 32
The question how mergers affect innovation has gained prominence in a number of recent merger cases. Accounting for the likely effects of mergers on innovation is difficult for a number of reasons though. First of all, the relationship between market concentration and innovation is far from...
Persistent link: https://www.econbiz.de/10011722144
We analyze the efficiency defense in merger control. First, we show that the relationship between exogenous efficiency gains and social welfare can be non-monotone. Second, we consider both endogenous mergers and endogenous efficiencies and find that merger proposals are largely aligned with a...
Persistent link: https://www.econbiz.de/10010309799
Persistent link: https://www.econbiz.de/10001617426
Persistent link: https://www.econbiz.de/10001782009
We analyze evidence production in merger control as a delegation problem in an inquisitorial competition policy system. The antitrust agency’s incentives to produce evidence on the efficiency of a merger proposal depend critically on its action set. Allowing for a compromising remedy solution...
Persistent link: https://www.econbiz.de/10013243241
Persistent link: https://www.econbiz.de/10001635926
We analyze horizontal mergers when the acquirer holds a passive partial ownership stake (PPO) in the target firm prior to the merger. We show that a PPO reduces the minimal synergy level necessary to make a merger beneficial for consumers. It follows that an antitrust authority ignoring existing...
Persistent link: https://www.econbiz.de/10009788178
We analyze the efficiency defense in merger control. First, we show that the relationship between exogenous efficiency gains and social welfare can be non-monotone. Second, we consider both endogenous mergers and endogenous efficiencies and find that merger proposals are largely aligned with a...
Persistent link: https://www.econbiz.de/10009572245
We investigate how remedies in merger control affect information acquisition by an antitrust agency. We identify conditions under which an ''extreme options'' regime which does not allow for remedies improves information acquisition by the agency which increases consumer surplus. The legislator...
Persistent link: https://www.econbiz.de/10010484386
Persistent link: https://www.econbiz.de/10010504784